References:
1. Chen A, Coura-Filho GB, Rehder M. Clinical Characteristics of
Covid-19 in China. N Engl J Med 2020;382:1860.
2. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological
findings and complications of COVID-19. American Journal of Hematology
2020.
3. Zhang T, Sun LX, Feng RE. [Comparison of clinical and pathological
features between severe acute respiratory syndrome and coronavirus
disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:E040.
4. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in
patients with severe novel coronavirus pneumonia. Journal of Thrombosis
and Haemostasis 2020.
5. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19
patients. Emerg Microbes Infect 2020;9:687-690.
6. Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk
and anticoagulant therapy in COVID-19 patients: emerging evidence and
call for action. Br J Haematol 2020.
7. World Health Organization. Clinical management of severe acute
respiratory infection when novel coronavirus (nCoV) infection is
suspected: interim guidance. Published January 28, 2020. Accessed
January 31, 2020. https://www.who.int/publications-detai
8. National Health Commission of China. The diagnosis and treatment plan
for the novel coronavirus disease (the seventh edition). 2020.
9. Coronavirus disease (COVID-2019) R&D. Geneva: World Health
Organization. https://www.who.int/blueprint/ priority-diseases/key
-action/novel -coronavirus/en/
10. Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer.
Journal of the American College of Cardiology 2017;70:2411-2420.
11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. Journal of Thrombosis and Haemostasis 2020;18:844-847.
12. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute
Respiratory Distress Syndrome and Death in Patients With Coronavirus
Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.
13. Oudkerk M, Buller HR, Kuijpers D, et al. Diagnosis, Prevention, and
Treatment of Thromboembolic Complications in COVID-19: Report of the
National Institute for Public Health of the Netherlands. Radiology
2020:201629.
14. Z Varga: Endothelial cell infection and endotheliitis in COVID-19.
The Lancet’s website.
https://www.thelancet.com/lancet/article/s0140-6736(20)30937-5.
Published April 17, 2020. Assessed April 19,2020.
15. LEONARD-LORANT L, Xavier D, HELMS, et al. Acute Pulmonary Embolism
in COVID-19 Patients on CT Angiography and Relationship to D-Dimer
Levels. Radiology 2020.
16. Wang T, Chen R, Liu C, et al. Attention should be paid to venous
thromboembolism prophylaxis in the management of COVID-19. The Lancet
Haematology 2020;7:e362-e363.
17. Ji H, Zhao R, Matalon S, et al. Elevated Plasmin(ogen) as a Common
Risk Factor for COVID-19 Susceptibility. Physiological Reviews
2020;100:1065-1075.
18. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated
with decreased mortality in severe coronavirus disease 2019 patients
with coagulopathy. J Thromb Haemost 2020;18:1094-1099.
19. Lin L, Lu L, Cao W, et al. Hypothesis for potential pathogenesis of
SARS-CoV-2 infection-a review of immune changes in patients with viral
pneumonia. Emerg Microbes Infect 2020;9:727-732.